Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Nurix Therapeutics (NRIX) Receivables Refunds (2020 - 2022)

Historic Receivables Refunds for Nurix Therapeutics (NRIX) over the last 3 years, with Q1 2022 value amounting to $204000.0.

  • Nurix Therapeutics' Receivables Refunds fell 9487.57% to $204000.0 in Q1 2022 from the same period last year, while for Feb 2022 it was $204000.0, marking a year-over-year decrease of 9487.57%. This contributed to the annual value of $204000.0 for FY2021, which is 9469.58% down from last year.
  • As of Q1 2022, Nurix Therapeutics' Receivables Refunds stood at $204000.0, which was down 9487.57% from $204000.0 recorded in Q4 2021.
  • Over the past 5 years, Nurix Therapeutics' Receivables Refunds peaked at $4.0 million during Q1 2021, and registered a low of $204000.0 during Q3 2021.
  • Its 3-year average for Receivables Refunds is $2.2 million, with a median of $3.1 million in 2021.
  • Its Receivables Refunds has fluctuated over the past 5 years, first crashed by 9469.58% in 2021, then crashed by 9487.57% in 2022.
  • Over the past 3 years, Nurix Therapeutics' Receivables Refunds (Quarter) stood at $3.8 million in 2020, then tumbled by 94.7% to $204000.0 in 2021, then changed by 0.0% to $204000.0 in 2022.
  • Its Receivables Refunds was $204000.0 in Q1 2022, compared to $204000.0 in Q4 2021 and $204000.0 in Q3 2021.